Effects of dexmedetomidine on postoperative renal function and early recovery quality in neoadjuvant chemotherapy in tumor patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027182

Enrollment

Unknown

Registered

2019-11-04

Start date

2019-10-29

Completion date

Unknown

Last updated

2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

turnor patients

Interventions

experimental group:dexmedetomidine

control group:normal saline

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Aged over 18 years; ASA grade I-III; Signed informed consent by patient.

Exclusion criteria

Exclusion criteria: Heart disease history, known hypersensitivity to anaesthetic drugs; neurological or psychiatric disorders; with seriuos liver and kidney dysfunction.

Design outcomes

Primary

Measure	Time frame
neutrophil gelatinase associated lipocalin;cystatin C;	—

Secondary

Measure	Time frame
visual satisfaction scale;Dimension score of recovery quality scale;Ramsay sedation score;	—

Countries

China

Contacts

Public ContactHuiqun Jia

The Fourth Hospital of Hebei Medical University

mazuixueke@sina.com+86 13903211399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026